GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SciBase Holding AB (OSTO:SCIB) » Definitions » Total Equity

SciBase Holding AB (OSTO:SCIB) Total Equity : kr37.89 Mil (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is SciBase Holding AB Total Equity?

SciBase Holding AB's total equity for the quarter that ended in Sep. 2024 was kr37.89 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


SciBase Holding AB Total Equity Historical Data

The historical data trend for SciBase Holding AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SciBase Holding AB Total Equity Chart

SciBase Holding AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.01 46.86 70.80 25.24 43.06

SciBase Holding AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.40 43.06 29.44 52.90 37.89

SciBase Holding AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

SciBase Holding AB's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=64.334-21.277
=43.06

SciBase Holding AB's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity=Total Assets(Q: Sep. 2024 )-Total Liabilities(Q: Sep. 2024 )
=56.079-18.188
=37.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SciBase Holding AB Total Equity Related Terms

Thank you for viewing the detailed overview of SciBase Holding AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


SciBase Holding AB Business Description

Traded in Other Exchanges
N/A
Address
Landsvagen 39, Sundbyberg, Stockholm, SWE, 172 63
SciBase Holding AB is a medical technology company that develops devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. SciBase's products include Nevisense and Nevisense Go and to date, the platform addresses the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. It is the only FDA-approved device for the detection of melanoma and the only MDR-approved technology for skin cancer detection in Europe. The company operates in two segments which includes skin cancer and skin barrier assessment. Majority of the revenue is generated from skin cancer segment. Its geographical segments are Europe/Rest of the World, the United States/North America, and Asia/Oceania.

SciBase Holding AB Headlines

No Headlines